ON-013100
CAY-43947-25 25 mg
Data Sheet: 
CAS
865783-95-5
Formulation
A solid
Purity
≥95%
MW
394,438
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A cell cycle inhibitor; induces cell cycle arrest at the G2/M phase in Granta 519 cells at 1 µM; decreases levels of MDM2, cyclin D1, and Cdk4 and increases levels of cyclin B1 in Granta 519 cells; induces apoptosis in Granta 519 cells at 0.01 µM; induces cytotoxicity in Granta 519 and Z-138C cells at 1 or 10 µM in combination with doxorubicin or vincristine
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
